06/16/2016
Federal Register Notice: FDA is making available a draft guidance entitled Factors to Consider Regarding Benefit-Risk in Medical D...06/16/2016
Federal Register Notice: FDA is making available a guidance entitled Use of International Standard ISO 10993-1, `Biological evalua...06/16/2016
Federal Register Notice: FDA’s Office of Pediatric Therapeutics, and the Eunice Kennedy Shriver National Institute of Child ...06/16/2016
Federal Register Notice: FDA will hold a meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee6...12/14/2015
Federal Register Notice: FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet 2/18/16,...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Janssen Pharmaceutica’s Sirturo is 2,213 days f...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Bristol-Myers Squibb’s Eliquis is 3,685 days fo...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Second Sight Medical Products’ Argus II Visual ...